{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T09:28:59Z","timestamp":1770888539264,"version":"3.50.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,4,21]],"date-time":"2022-04-21T00:00:00Z","timestamp":1650499200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,4,21]],"date-time":"2022-04-21T00:00:00Z","timestamp":1650499200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"The Clinical Project of the Second Affiliated Hospital of Kunming Medical University","award":["2020ynlc006"],"award-info":[{"award-number":["2020ynlc006"]}]},{"name":"Graduate Innovation Fund of Kunming Medical University in 2021","award":["2021D10"],"award-info":[{"award-number":["2021D10"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"DOI":"10.1007\/s10238-022-00823-2","type":"journal-article","created":{"date-parts":[[2022,4,21]],"date-time":"2022-04-21T08:04:04Z","timestamp":1650528244000},"page":"511-518","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Assessment of anti-desmoglein antibodies levels and other laboratory indexes as objective comprehensive indicators of patients with pemphigus vulgaris of different severity: a single-center retrospective study"],"prefix":"10.1007","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9581-280X","authenticated-orcid":false,"given":"Xiaoying","family":"Lin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaolan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,4,21]]},"reference":[{"issue":"10201","key":"823_CR1","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/S0140-6736(19)31778-7","volume":"394","author":"E Schmidt","year":"2019","unstructured":"Schmidt E, Kasperkiewicz M, Joly P. Pemphigus. Lancet. 2019;394(10201):882\u201394.","journal-title":"Lancet"},{"issue":"6","key":"823_CR2","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1111\/bjd.17591","volume":"180","author":"I Ujiie","year":"2019","unstructured":"Ujiie I, Ujiie H, Iwata H, Shimizu H. Clinical and immunological features of pemphigus relapse. Br J Dermatol. 2019;180(6):1498\u2013505.","journal-title":"Br J Dermatol"},{"issue":"9","key":"823_CR3","first-page":"4223","volume":"28","author":"H Sibel Berksoy","year":"2017","unstructured":"Sibel Berksoy H, Rukiye G, Melih A. Blood mean platelet volume may be predictive for disease course in the cases with pemphigus vulgaris. Biomed Res. 2017;28(9):4223\u20137.","journal-title":"Biomed Res"},{"issue":"6","key":"823_CR4","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1111\/j.1365-2133.2009.09474.x","volume":"161","author":"Y Wohl","year":"2009","unstructured":"Wohl Y, Dreiher J, Cohen AD. Pemphigus and dyslipidaemia: a case-control study. Br J Dermatol. 2009;161(6):1418\u201320.","journal-title":"Br J Dermatol"},{"issue":"6","key":"823_CR5","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/j.jaad.2008.01.012","volume":"58","author":"DF Murrell","year":"2008","unstructured":"Murrell DF, Dick S, Ahmed AR, et al. Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus. J Am Acad Dermatol. 2008;58(6):1043\u20136.","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"823_CR6","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1684\/ejd.2012.1903","volume":"23","author":"E Cozzani","year":"2013","unstructured":"Cozzani E, Di Zenzo G, Riva S, et al. Are clinical phenotype and autoantibody profile always concordant in pemphigus? A study in a cohort of pemphigus patients. Eur J Dermatol. 2013;23(1):40\u20138.","journal-title":"Eur J Dermatol"},{"issue":"3","key":"823_CR7","doi-asserted-by":"publisher","first-page":"223","DOI":"10.3109\/15569527.2013.834498","volume":"33","author":"BB Sen","year":"2014","unstructured":"Sen BB, Rifaioglu EN, Ekiz O, Inan MU, Sen T, Sen N. Neutrophil to lymphocyte ratio as a measure of systemic inflammation in psoriasis. Cutan Ocul Toxicol. 2014;33(3):223\u20137.","journal-title":"Cutan Ocul Toxicol"},{"issue":"1","key":"823_CR8","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1755-7682-5-2","volume":"5","author":"F Imtiaz","year":"2012","unstructured":"Imtiaz F, Shafique K, Mirza SS, Ayoob Z, Vart P, Rao S. Neutrophil lymphocyte ratio as a measure of systemic inflammation in prevalent chronic diseases in Asian population. Int Arch Med. 2012;5(1):2.","journal-title":"Int Arch Med"},{"issue":"6","key":"823_CR9","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1159\/000512916","volume":"237","author":"A Lyakhovitsky","year":"2021","unstructured":"Lyakhovitsky A, Dascalu J, Drousiotis T, Barzilai A, Baum S. Hematological inflammatory markers in patients with pemphigus vulgaris. Dermatology. 2021;237(6):912\u201320.","journal-title":"Dermatology"},{"issue":"1","key":"823_CR10","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1177\/0003319715574625","volume":"67","author":"MK Akboga","year":"2016","unstructured":"Akboga MK, Canpolat U, Balci KG, et al. Increased platelet to lymphocyte ratio is related to slow coronary flow. Angiology. 2016;67(1):21\u20136.","journal-title":"Angiology"},{"issue":"1","key":"823_CR11","doi-asserted-by":"publisher","first-page":"47","DOI":"10.2174\/138161211795049804","volume":"17","author":"AY Gasparyan","year":"2011","unstructured":"Gasparyan AY, Ayvazyan L, Mikhailidis DP, Kitas GD. Mean platelet volume: a link between thrombosis and inflammation? Curr Pharm Des. 2011;17(1):47\u201358.","journal-title":"Curr Pharm Des"},{"issue":"1","key":"823_CR12","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1007\/s12072-015-9665-6","volume":"10","author":"R Spinella","year":"2016","unstructured":"Spinella R, Sawhney R, Jalan R. Albumin in chronic liver disease: structure, functions and therapeutic implications. Hep Int. 2016;10(1):124\u201332.","journal-title":"Hep Int"},{"issue":"3","key":"823_CR13","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1111\/ced.12489","volume":"40","author":"MH Javanbakht","year":"2015","unstructured":"Javanbakht MH, Djalali M, Daneshpazhooh M, et al. Evaluation of antioxidant enzyme activity and antioxidant capacity in patients with newly diagnosed pemphigus vulgaris. Clin Exp Dermatol. 2015;40(3):313\u20137.","journal-title":"Clin Exp Dermatol"},{"issue":"2","key":"823_CR14","doi-asserted-by":"crossref","first-page":"57","DOI":"10.21315\/mjms2020.27.2.7","volume":"27","author":"F Rezazadeh","year":"2020","unstructured":"Rezazadeh F, Moshaverinia M, Handjani F, Khoshkholgh F, Saki N, Heiran A. The evaluation of serum lipids profile in patients with pemphigus vulgaris: a case-control study. Malays J Med Sci. 2020;27(2):57\u201363.","journal-title":"Malays J Med Sci"},{"issue":"5","key":"823_CR15","doi-asserted-by":"publisher","first-page":"599","DOI":"10.23736\/S0392-0488.18.06073-X","volume":"153","author":"C Feliciani","year":"2018","unstructured":"Feliciani C, Cozzani E, Marzano AV, et al. Italian guidelines in pemphigus\u2014adapted from the European Dermatology Forum (EDF) and European Academy of Dermatology and Venerology (EADV). G Ital Dermatol Venereol. 2018;153(5):599\u2013608.","journal-title":"G Ital Dermatol Venereol"},{"issue":"3","key":"823_CR16","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.jaad.2018.02.021","volume":"82","author":"DF Murrell","year":"2020","unstructured":"Murrell DF, Pe\u00f1a S, Joly P, et al. Diagnosis and management of pemphigus: recommendations of an international panel of experts. J Am Acad Dermatol. 2020;82(3):575\u201385.","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"823_CR17","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1111\/bjd.15930","volume":"177","author":"KE Harman","year":"2017","unstructured":"Harman KE, Brown D, Exton LS, et al. British Association of Dermatologists\u2019 guidelines for the management of pemphigus vulgaris 2017. Br J Dermatol. 2017;177(5):1170\u2013201.","journal-title":"Br J Dermatol"},{"issue":"3","key":"823_CR18","doi-asserted-by":"publisher","first-page":"317","DOI":"10.4103\/ijdvl.IJDVL_1078_14","volume":"83","author":"J Gupta","year":"2017","unstructured":"Gupta J, Raval RC, Shah AN, et al. Low-dose rituximab as an adjuvant therapy in pemphigus. Indian J Dermatol Venereol Leprol. 2017;83(3):317\u201325.","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"4","key":"823_CR19","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1016\/j.jaad.2017.11.024","volume":"78","author":"K Vinay","year":"2018","unstructured":"Vinay K, Cazzaniga S, Amber KT, Feldmeyer L, Naldi L, Borradori L. Rituximab as first-line adjuvant therapy for pemphigus: retrospective analysis of long-term outcomes at a single center. J Am Acad Dermatol. 2018;78(4):806\u20138.","journal-title":"J Am Acad Dermatol"},{"key":"823_CR20","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.intimp.2017.11.005","volume":"54","author":"S Tavakolpour","year":"2018","unstructured":"Tavakolpour S, Mahmoudi H, Balighi K, Abedini R, Daneshpazhooh M. Sixteen-year history of rituximab therapy for 1085 pemphigus vulgaris patients: a systematic review. Int Immunopharmacol. 2018;54:131\u20138.","journal-title":"Int Immunopharmacol"},{"issue":"6","key":"823_CR21","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1016\/j.jaad.2017.07.012","volume":"77","author":"LN Albers","year":"2017","unstructured":"Albers LN, Liu Y, Bo N, Swerlick RA, Feldman RJ. Developing biomarkers for predicting clinical relapse in pemphigus patients treated with rituximab. J Am Acad Dermatol. 2017;77(6):1074\u201382.","journal-title":"J Am Acad Dermatol"},{"issue":"12","key":"823_CR22","doi-asserted-by":"publisher","first-page":"2850","DOI":"10.1038\/jid.2008.172","volume":"128","author":"R Eming","year":"2008","unstructured":"Eming R, Nagel A, Wolff-Franke S, Podstawa E, Debus D, Hertl M. Rituximab exerts a dual effect in pemphigus vulgaris. J Invest Dermatol. 2008;128(12):2850\u20138.","journal-title":"J Invest Dermatol"},{"issue":"1","key":"823_CR23","first-page":"1","volume":"53","author":"Dermatology Branch of China International Exchange and Promotion Association for Medical and Healthcare","year":"2020","unstructured":"Dermatology Branch of China International Exchange and Promotion Association for Medical and Healthcare. [Diagnosis and treatment of pemphigus vulgaris: an expert proposal]. Chin J Dermatol. 2020;53(1):1\u20137.","journal-title":"Chin J Dermatol"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-022-00823-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-022-00823-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-022-00823-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,22]],"date-time":"2024-09-22T16:55:03Z","timestamp":1727024103000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-022-00823-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,21]]},"references-count":23,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,6]]}},"alternative-id":["823"],"URL":"https:\/\/doi.org\/10.1007\/s10238-022-00823-2","relation":{},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,21]]},"assertion":[{"value":"6 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interests regarding the publication of this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}